Bank of America’s iTeos Therapeutics ITOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.08M | Buy |
308,660
+128,556
| +71% | +$1.28M | ﹤0.01% | 3680 |
|
|
2025
Q1 | $1.08M | Buy |
180,104
+118,773
| +194% | +$709K | ﹤0.01% | 4309 |
|
|
2024
Q4 | $471K | Sell |
61,331
-15,435
| -20% | -$119K | ﹤0.01% | 4754 |
|
|
2024
Q3 | $784K | Sell |
76,766
-7,270
| -9% | -$74.2K | ﹤0.01% | 4419 |
|
|
2024
Q2 | $1.25M | Buy |
84,036
+28,289
| +51% | +$420K | ﹤0.01% | 4051 |
|
|
2024
Q1 | $760K | Sell |
55,747
-8,931
| -14% | -$122K | ﹤0.01% | 4325 |
|
|
2023
Q4 | $708K | Sell |
64,678
-38,797
| -37% | -$425K | ﹤0.01% | 4393 |
|
|
2023
Q3 | $1.13M | Sell |
103,475
-12,389
| -11% | -$136K | ﹤0.01% | 3950 |
|
|
2023
Q2 | $1.53M | Sell |
115,864
-41,766
| -26% | -$553K | ﹤0.01% | 3727 |
|
|
2023
Q1 | $2.15M | Sell |
157,630
-314,885
| -67% | -$4.29M | ﹤0.01% | 3666 |
|
|
2022
Q4 | $9.23M | Buy |
472,515
+126,495
| +37% | +$2.47M | ﹤0.01% | 2347 |
|
|
2022
Q3 | $6.59M | Buy |
346,020
+195,774
| +130% | +$3.73M | ﹤0.01% | 2580 |
|
|
2022
Q2 | $3.1M | Buy |
150,246
+10,667
| +8% | +$220K | ﹤0.01% | 3359 |
|
|
2022
Q1 | $4.49M | Buy |
139,579
+50,521
| +57% | +$1.63M | ﹤0.01% | 3243 |
|
|
2021
Q4 | $4.15M | Buy |
89,058
+66,694
| +298% | +$3.1M | ﹤0.01% | 3283 |
|
|
2021
Q3 | $604K | Buy |
22,364
+14,448
| +183% | +$390K | ﹤0.01% | 4720 |
|
|
2021
Q2 | $203K | Buy |
7,916
+1,753
| +28% | +$45K | ﹤0.01% | 5326 |
|
|
2021
Q1 | $211K | Buy |
6,163
+4,509
| +273% | +$154K | ﹤0.01% | 5341 |
|
|
2020
Q4 | $56K | Sell |
1,654
-372
| -18% | -$12.6K | ﹤0.01% | 5524 |
|
|
2020
Q3 | $50K | Buy |
+2,026
| New | +$50K | ﹤0.01% | 5368 |
|